A2AR |
A2A-receptor |
ADO |
Extracellular adenosine |
CA-IX |
Carbonic anhydrase IX |
CCR |
CC chemokine receptors |
CNS |
Central nervous system |
CTL |
Cytotoxic T-lymphocyte |
CTLA-4 |
Cytotoxic-T-lymphocyte protein 4 |
DAPI |
4′,6-diamidino-2-phenylindole |
GLUT |
Glucose transporter |
H&E |
Hematoxylin and eosin |
HIF |
Hypoxia-inducible factor |
HRP |
Horseradish peroxidase |
ICD |
Immunogenic cell death |
ICI |
Immune checkpoint inhibitor |
IF |
Immunofluorescence |
IHC |
Immunohistochemistry |
IL |
Interleukin |
IPI |
Ipilimumab |
LAG3 |
Lymphocyte-activation gene 3 |
LN |
Lymph node |
mAb |
Monoclonal antibody |
MBM |
Melanoma brain metastases |
OS |
Overall survival |
PD-1 |
Programmed cell death protein 1 |
ROI |
Region of interest |
RT |
Radiotherapy |
STX |
Stereotactic brain radiotherapy |
TIL |
Tumor-infiltrating lymphocytes |
TME |
Tumor microenvironment |
WBRT |
Whole-brain radiotherapy |